Cart
sales@molnova.com
Parimifasor
CAS No. 1796641-10-5
Parimifasor( LYC-30937-EC | LYC30937 )
Catalog No. M12714 CAS No. 1796641-10-5
Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 2MG | 54 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 407 | In Stock |
|
| 100MG | 602 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameParimifasor
-
NoteResearch use only, not for human use.
-
Brief DescriptionParimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
-
DescriptionParimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).Psoriasis Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsLYC-30937-EC | LYC30937
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
IndicationPsoriasis
Chemical Information
-
CAS Number1796641-10-5
-
Formula Weight460.214
-
Molecular FormulaC18H11Cl2F4N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥150 mg/mL （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(/N=C(NC1=CC(F)=CC(Cl)=C1)\NC2=NNC(C(F)(F)F)=C2)C3=CC=CC(Cl)=C3
-
Chemical Name3-chloro-N-[(3-chloro-5-fluoroanilino){[5-(trifluoromethyl)-1H-pyrazol-3-yl]amino}methylidene]benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
3-Hydroxy-2,4,7-Trim...
3-Hydroxy-2,4,7-Trimethoxyflavone
-
NSC 694623
NSC 694623 is a potent histone acetyltransferase (HAT) inhibitor with an IC50 of 15.9 μM against recombinant HAT p300/CBP-associated factor (PCAF) and exhibits anti-proliferative activity against certain cancer cells, making it useful for anti-cancer research.
-
Biotin-LC-LC-NHS
Biotin-LC-LC-NHS, an SMCC cross-linking reagent, acts as a labeling agent for antibodies and small molecules (like Paclitaxel).
